Prelude Therapeutics PRLD
NASDAQ PRLD
$3.96 +0.05 (+1.28%)
At close: Sep 29, 2026 · 4:00 PM EDT

Prelude Therapeutics (PRLD) Revenue (2024 - 2026)

Updated

Prelude Therapeutics' Revenue came in at $5.7 million for Q2 2026, up 24.5% from the prior quarter.

Analysis

Prelude Therapeutics (PRLD) Revenue (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Prelude Therapeutics reported Revenue of $22.42 million, up 220.3% year-over-year; for FY2025, it came in at $12.14 million, up 73.4% from FY2024.

  • Going back by year, Revenue was $7 million in FY2024.
  • The five-year range for quarterly Revenue is $3 million (Q3 2024) to $6.5 million (Q3 2025).
  • Business Quant data shows PRLD's Revenue at $4.58 million (Q1 2026), $5.64 million (Q4 2025) and $6.5 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.31 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 16.99 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.38 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.33 Bn
10 Prelude Therapeutics 312.03 Mn -285.27 Mn - 5.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.70 Mn
Mar 31, 2026 4.58 Mn
Dec 31, 2025 5.64 Mn
Sep 30, 2025 6.50 Mn
Dec 31, 2024 4.00 Mn
Sep 30, 2024 3.00 Mn
API Access

Prelude Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=PRLD&period=max&api_key=YOUR_API_KEY